The WACC of BioMark Diagnostics Inc (BUX.CN) is 5.6%.
| Range | Selected | |
| Cost of equity | 4.40% - 6.90% | 5.65% |
| Tax rate | 25.90% - 26.50% | 26.20% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 4.4% - 6.8% | 5.6% |
| Category | Low | High |
| Long-term bond rate | 3.3% | 3.8% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.13 | 0.35 |
| Additional risk adjustments | 0.5% | 1.0% |
| Cost of equity | 4.40% | 6.90% |
| Tax rate | 25.90% | 26.50% |
| Debt/Equity ratio | 0.04 | 0.04 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 4.4% | 6.8% |
| Selected WACC | 5.6% | |